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CHAPTER 1 
                                                                                                                                  
INTRODUCTION 
RNAi discovery and downstream mediators 
 RNA interference (RNAi) was demonstrated in a landmark article that revealed 
potent sequence specific gene silencing via double-stranded RNA injection in C. elegans 
(Fire et al., 1998). These ground-breaking experiments revealed that double-stranded 
sequences corresponding to exonic sequences produced silencing of complementary 
mRNA transcripts, whereas intronic and promoter sequences had no effect. Specifically, 
sense or antisense RNA individually had modest to little effect on the target gene 
compared to mutant phenotypes observed with double-stranded RNA (dsRNA). A similar 
twitching phenotype in progeny of injected animals was produced following injection of 
unc-22 dsRNA when compared to animals with loss-of-function mutations, consistent 
with disruption of myofilament protein motile function.  This novel silencing mechanism 
was capable of crossing cellular boundaries and traversing into the germline. 
Additionally, the robust silencing and targeting of genes distant from the site of injection 
suggested the involvement of a catalytic component and/or RNA-transport mechanism.  
This essential discovery ushered in an era of reverse genetic studies aimed at deciphering 
the RNAi pathway and elucidating key mediators of this process. The rest of this 
introduction will highlight major milestones in elucidating the RNAi pathway and focus 
on two important mediators of RNAi---microRNAs (miRNAs) and small interfering 
RNAs (siRNAS). The history of these small ~23-25 nucleotide (nt) noncoding RNA 
molecules and their roles in gene regulation including post-transcriptional gene silencing 
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(PTGS – referring to RNA suppression) and transcriptional gene silencing (TGS – 
referring to DNA suppression) will be expanded upon. 
  
miRNA and siRNA biogenesis and Post-Transcriptional Gene Silencing 
 Vertebrate model systems paved the way in the discovery of miRNAs, with the 
initial discovery in C. elegans. Consistent with the interference of mRNA expression 
through binding with an RNA via sequence complementarity, the detection of miRNAs as 
small RNA molecules with antisense sequences to mRNAs suggested an RNAi-like 
mechanism. However, the novel discovery of the first miRNA lin-4 in 1993 wasn’t fully 
appreciated until after the Fire and Mello breakthrough of RNAi five years later (Lee et 
al., 1993). RNAi provided a logical explanation for the behavior observed with inhibition 
of LIN-14 protein production by lin-4 during the first larval steps of C. elegans 
development. Chromosomal walking and transformation rescue analysis showed that lin-
4 encoded a small RNA and genomic comparison indicated that lin-4 had sequence 
complementarity to the 3’untranslated region (UTR) of the mRNA encoding LIN-14. 
These observations led to the hypothesis that lin-4 inhibited LIN-14 protein levels via an 
antisense RNA-RNA interaction. Interestingly, lin-4 was found to reside in an intronic 
region of an unknown host gene which suggested temporal regulation of its expression. 
Although premature, the authors proposed the potential involvement of a stable complex 
mediating the hypothesized RNA-RNA interaction with possible crosstalk with the 
translation machinery. 
 Despite progress on the mechanism of RNAi, the miRNA field remained limited 
until the discovery of a second miRNA in C. elegans (Reinhart et al., 2000). RNA 
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expression analysis and mutant allele sequencing demonstrated that let-7 encoded a small 
untranslated RNA of 21nt in length and its expression was shown to be temporally 
regulated with peak expression at early L4 and adult stages but not in the L1 or L2 stages. 
Similar to lin-4, let-7 sequence was found to be complementary to the 3’UTR of the LIN-
41 gene, in addition to other genes. Further experiments indicated that let-7 functioned as 
a temporal switch between larval and adult fates. Based on sequence conservation, 
numerous miRNAs were then discovered in multiple species prompting studies aimed at 
elucidating miRNA regulation and mechanism (Bartel D., 2004).  
An effective method for studying mechanism is generating an in vitro system with  
limited components to recapitulate in vivo events. Using a cell free system derived from 
syncytial blastoderm Drosophila embryos, incubation of reporter mRNAs with 
corresponding dsRNAs produced sequence specific silencing (Tuschl et al., 1999). The 
effects of the dsRNA suggested direct destabilization of the target mRNA and serial 
dilution of dsRNA up to 64-fold produced silencing similar to undiluted dsRNA (Tuschl 
et al., 1999). Another key finding using cell free assays demonstrated sequence specific 
RNAi using Drosophila S2 cells, in which a Ca2+ dependent nuclease with an RNA 
component mediated silencing. Biochemical fractionation suggested that the nuclease 
might be a ribonucleoprotein. The term RNA-Induced Silencing Complex or RISC was 
coined to describe this complex. Due to an association of RNA species of 25 nt 
homologous to the target, a model developed where small RNAs served as guides for 
targeting of specific messages based upon sequence recognition (Hammond et al. 2000). 
A strikingly similar observation was shown in plants, whereby 25 nt antisense transcripts 
were detected after transforming plants with cDNA sequences, further supporting small 
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RNAs as determinants of PTGS (Hamilton and Baulcombe, 1999). Around the same 
time, another report observed degradation of homologous RNAs and showed that the 
dsRNA was processed to small ~21-23 nt RNA fragments (Zamore et al., 2000). These 
studies proposed the hypothesis that the 21-23 nt RNA fragments mediated RNAi via 
detection of radiolabeled 21-23 nt RNAs following incubation of radiolabeled dsRNA 
with Drosophila embryo lysates. These synthetic RNA species were termed small 
interfering RNAs or siRNAs with the characteristic of perfect complementarity to their 
target. Purification of 21-23 nt RNAs revealed the presence of 2’ and 3’ hydroxyl groups, 
and responsiveness to alkaline phosphatase implied the presence of a 5’ phosphate group, 
which suggested processing of dsRNA in an RNase III- like manner.  Furthermore, these 
authors showed that chemically synthesized siRNA duplexes harboring overhanging 3’ 
ends mediated gene silencing (Elbashir et al., 2000). Taken together, these studies 
illustrated that exogenous delivery of dsRNA elicited sequence specific silencing, similar 
to the PTGS mechanism of silencing in plants (Bartel, D., 2004). 
 PTGS in plants produced a reduction of RNA molecules with sequence similarity 
to foreign or endogenous DNA that was initially introduced. Triggers of PTGS include 
internal inverted repeat transgenes or co-expression of sense and antisense transgenes 
(Waterhouse et al, 1998, Hamilton et al., 1999, Chuang et al., 2000). A set of related 
proteins (SGS2/QDE-1/EGO-1) shared by PTGS in plants, quelling in Neurospora, and 
RNAi in animals provided proof that these pathways are functionally linked. A related 
protein encoded the AGO1 gene was shown to be required for PTGS in Arabidopsis 
thaliana plants as AGO1 mutants were defective in gene silencing (Fagard et al., 2000). 
This finding was further corroborated with purification and identification of AGO2 as an 
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essential component of RISC, a required protein for RNAi in vitro (Hammond et al., 
2001), and later described as the catalytic enzyme responsible for mRNA cleavage or 
‘slicer’ activity in mammals (Liu et al., 2004)  
 Subsequent experiments identified the RNase III enzyme, Dicer as responsible for 
cleavage of long dsRNA into smaller dsRNA duplexes in Drosophila (Bernstein et al., 
2000). Dicer was found to belong to the class of RNase III-like enzymes (dependent on 
ATP) harboring two RNAse III signature motifs for cleavage, a dsRNA-binding domain, 
a PAZ (Piwi, Argo, and Zwille/Pinhead) domain, and an amino-terminal helicase domain. 
Cleavage products of RNAse III enzymes contain 2 to 3 nt 3’ overhangs, 5’phosphate, 
and 3’hydroxyl termini. In addition, fractionation methods demonstrated that Dicer 
activity was distinct from RISC, providing a model of sequential processing of dsRNA 
with Dicer acting upstream of RISC (Bernstein et al., 2001). Through analysis of mature 
let-7 miRNA transcripts after maturation in vitro from longer let-7 precursor transcripts, 
human Dicer was shown to regulate let-7, thus, linking siRNA and miRNA pathways. 
Following Dicer inhibition, precursor let-7 RNA accumulated in Hela cells with 
reduction of mature let-7 transcripts, implicating the RNAi enzyme Dicer for maturation 
of human let-7 RNA (Hutvágner et al., 2001).  
 Further association between the two families of small noncoding RNAs was 
demonstrated with the finding that siRNAs silenced target mRNAs via base pairing, 
similar to miRNAs (Doench et al., 2003). Initially, pairing of a miRNA with its target 
mRNA was thought to result in translational inhibition whereas siRNA pairing results in 
degradation (Doench et al, 2003). To further identify other enzymes responsible for 
miRNA processing with particular focus on primary miRNA transcripts, the RNase III 
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enzyme Drosha was identified as the enzyme responsible for cleavage of primary 
transcripts in the nucleus. Drosha was shown to release precursor miRNA transcripts in 
vitro and Drosha depletion produced accumulation of primary transcripts, further 
supporting a stepwise route of miRNA processing (Lee et al., 2003). A comparison 
between siRNAs and miRNAs is shown in Table 1 (Bartel, D., 2004) and a model of the 
miRNA biogenesis pathway is illustrated in Fig. 1. Of note, exogenously delivered 
siRNAs intersect with the miRNA biogenesis pathway from the Dicer processing step all 
the way to the target degradation step. 
 
Table 1.Comparison of siRNAs and miRNAS in PTGS  
 
siRNAs 
 
miRNAS 
~22 nt in  size ~21-25 nt in size 
Usually generated from exogenous 
introduction 
Usually endogenously transcribed from intronic 
or intergenic regions  
Derived from long dsRNA Derived from stem loop regions of long 
primary / precursor transcripts 
Cleavage by Dicer Stepwise cleavage by Drosha and Dicer 
Interact with RISC Interact with RISC 
Perfect complementarity to mRNA 
target 
Mostly imperfect complimentarity to mRNA 
target except ‘seed region’ 
 3’UTR, also CDS Mostly 3’UTR 
Mostly facilitate mRNA cleavage Mostly facilitate translational repression 
Multiple duplexes generated Single miRNA:miRNA* duplex from each 
hairpin precursor molecule 
Rarely conserved Mostly conserved in related organisms 
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Figure 1. The miRNA biogenesis pathway 
miRNAs are transcribed by RNA polymerase II as long primary transcripts called pri-
miRNAs with independent promoters or from intronic/exonic regions of protein-coding genes 
either in a polycistronic or monocistronic fashion. Nuclear Drosha and cofactor DGCR8 
cleave the base of the stem-loop to release precursor miRNAs (pre-miRNAs), which are 
transported to the cytoplasm by Exportin-5. Pre-miRNAs are recognized and cleaved by 
Dicer and cofactor TRBP releasing small ~22nt RNA duplexes. A guide strand is selected for 
incorporation into cytoplasmic RISC containing Ago proteins with the degradation of the 
passenger miRNA strand. The single stranded mature miRNA guides RISC to the 3’UTR 
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region of specific mRNA targets where AGO and GW182 families facilitate cleavage. Most 
miRNAs bind their target with imperfect complimentarity followed by translation repression 
with subsequent degradation, while perfect complementarity (usually observed with siRNAs) 
results in mRNA cleavage. Figure by Abby Olena. 
 
 
 
miRNAs in disease 
 
 Initially discovered as mediators of gene silencing during animal development 
and plant viral defense, miRNAs have been implicated in a variety of human diseases 
including neurodegenerative, cardiovascular, liver, and cancer (Fernández-Hernando, C., 
& Baldán, A., 2013, Goodall et al., 2013, Szabo, G. & Bala S., 2013, Esteller, M., 2011, 
Andrews, O., & Patton, J.P. , 2014). Cancer in particular is characterized by misregulated 
and/or altered cell division.  Most commonly, changes in cell cycle control arise from 
accumulated mutations leading to chromosomal instability, proliferation, and aggressive 
metastatic behavior. Changes in cancer cell behavior lead to a progression from benign to 
malignant stages (Fig. 2). Cancer is also fascinating because developmental pathways are 
often re-activated and commonly drive tumor progression. During animal development, 
miRNA expression has been shown to be temporally and spatially regulated (Thatcher et 
al., 2008 and Wei at al., 2012) and miRNAs have been shown to regulate multiple genes 
during development (Flynt et al., 2007, Li et al., 2011, Giraldez et al., 2006, Weinholds et 
al., 2005, Bernstein et al., 2003). Due to the observation of some miRNA target genes 
acting in common cancer pathways, the discovery of miRNAs as cancer promoters came 
as no surprise. More importantly, miRNAs have been shown to play roles in specific 
hallmarks of cancer as identified by Hanahan and Weinberg. These hallmarks are defined 
as acquired functional capabilities that allow cancer cells to survive, proliferate, and 
disseminate.  These shared characteristics include self-sufficiency from growth signals, 
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insensitivity to anti-growth signals, the ability to evade apoptosis, limitless replicative 
potential, sustained angiogenesis, tissue invasion, and metastasis (Hanahan, D., & 
Weinberg, R.A., 2000). Broadly, there are two defining feature of cancers: upregulation 
of oncogenes (genes having gain-of-function or abundant expression which promote 
cancer) and downregulation of tumor suppressor genes (genes having inhibitory cancer 
function whereby their loss-of-function promote cancer).  In the following sections, key 
oncogenic and tumor suppressor miRNAs will be described and a summary of miRNAs 
in steps of tumorigenesis will be shown in Table 2.  
 
 
 
Figure 2. Model of cancer progression  
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During the benign stage, cells acquire multiple mutations and form the primary tumor.  With 
increasing tumor growth, angiogenesis is initiated and cells locally invade during the 
malignant phase.  Aggressive metastasis results when tumor cells undergo epithelial-to-
mesenchymal transition (EMT), enter blood vessels, and colonize secondary sites through 
crosstalk in a tumor permissive microenvironment (Andrews, O., & Patton, J.G., 2014).  
 
 
 
miRNAs as oncogenes 
 The first report of an oncogenic miRNA showed that the miR-17-92 polycistron 
cluster is highly expressed in human B-cell lymphomas (He et al., 2005).  The miR-17-92 
cluster is located within a genomic locus on the chromosome 13q31 that was previously 
established as a frequently amplified region in cases of diffuse large B-cell lymphoma, 
follicular lymphoma, mantle cell lymphoma, primary cutaneous B-cell lymphoma, and 
other cancer types (Ota et al., 2004).  The cluster encodes miR-17-5p, 17-3p, 18, 19a, 20, 
19b-1, and 92-1.  One of the defining characteristics of an oncogene is chromosomal 
amplification and as a proof-of-principle, serial transplant assays are typically used to 
examine the tumor forming potential of a gene of interest.  Using a mouse model of 
human B-cell lymphoma, where the c-Myc oncogene is over-expressed by the 
immunoglobulin heavy chain enhancer (Eμ), He and colleagues (2005) demonstrated that 
the miR-17-19b cluster accelerated tumorigenesis (He et al., 2005). Transplantation of 
reconstituted hematopoietic stem cells (derived from Eμ-Myc mice) with miR-17-19b 
expression into irradiated recipient mice led to lymphoma development, invasion of 
tumor cells into other organs, and decreased survival.  Tumors continued to form after 
two rounds of serial transplantation and analysis of the tumor cell population for markers 
of pre-B and mature B cells (CD19 and IgM respectively) suggested that over-expression 
of the cluster favored transformation of B-cell progenitors (He et al., 2005). Another 
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study implicating the miR-17-92 cluster in lung tumorigenesis used northern blotting and 
detected increased miR-17-92 expression, increased copy number, and functionally 
enhanced lung cancer cell growth through cell proliferation assays (Hayashita et al., 
2005).  Thus, the miR-17-92 cluster can accurately be classified as oncogenic. 
 Further investigation of oncogenic miRNAs, or “oncomiRs” as they are 
designated, led to the detection of elevated miR-155 expression in lymphomas derived 
from B cells of different developmental stages (Eis et al., 2005).  Expression of miR-155 
(found on chromosome 21q21) was derived from sequences present in the bic RNA, 
which was previously discovered as a target for insertional mutagenesis in avian B-cell 
lymphomas (Tam et al., 1997).  bic cooperates with c-Myc (an established oncogene) in 
enhancing the growth and transformation potential of cultured chicken embryo 
fibroblasts.  In pancreatic ductal adenocarcinoma, miR-155 expression is upregulated and 
functional assays identified tumor protein 53 induced nuclear protein 1 (TP53INP1) as its 
target (Gironella et al., 2007).  Decreased TP53INP1 occurred through translational 
inhibition, providing a link between miR-155 and a regulator of cell cycle progression 
and apoptosis.  Further evidence for the oncogenic nature of miR-155 was observed in 
breast cancer (Jiang et al., 2010).  Over-expression of miR-155 triggered constitutive 
activation of growth pathways including the STAT3 and JAK pathways and its effects 
were mediated through targeting the tumor suppressor gene, Socs1 (Jiang et al., 2010).  
These experiments provided support for the contribution of miRNAs in tumorigenesis by 
downregulation of genes controlling cell growth and division, a mandatory prerequisite 
for primary tumor formation. 
 While initial findings of pro-tumorigenic miRNAs were mostly derived from 
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DNA copy number analyses, few have been identified through targeted approaches i.e. 
genetic screens.  Voorhoeve and colleagues (2006) designed a library of vectors 
expressing the majority of cloned human miRNAs and used microarrays to examine 
expression (Voorhoeve et al., 2006).  Through the use of an oncogenic stress model in 
which human fibroblasts express a constitutively active Ras, they discovered that vectors 
encoding miR-372 and miR-373 conferred a selective growth advantage to cells that 
would otherwise undergo a stress response, known as oncogene-induced senescence.  
Their results indicated that these miRNAs act in cooperation with Ras to promote 
tumorigenesis and also provided evidence implicating both miRNAs in tumors that 
retained a wild type (WT) copy of p53 but were nevertheless sensitive to DNA-damaging 
agents.  Analysis of chemosensitive testicular germ cell tumors harboring WT p53 
indicated high expression of miR-372 and miR-373 in tumors classified as embryonal 
carcinoma (Voorhoeve et al., 2006).  Also, germ cell lines failed to undergo growth arrest 
in the presence of a cell cycle inhibitor and miR-372 and miR-373.  Using prediction 
algorithms to identify targets whose 3’UTRs contained putative binding sites for both 
miRNAs, the serine threonine kinase Large Tumor Suppressor homolog 2 (LATS2) was 
identified and validated using a luciferase reporter assay.  Negative regulation of LATS2 
by miR-372 and miR-373 occurs through a combination of RNA ablation and inhibition 
of protein synthesis.  Since LATS2 is a tumor suppressor, its loss in mouse embryonic 
fibroblasts provides a growth advantage (Voorhoeve et al., 2006).  Together, miR-372 and 
miR-373 fit the oncogenic criteria because downregulation of their mRNA targets prevent 
exit from the cell cycle resulting in uncontrolled cell growth. 
 The classification of miRNAs as oncogenes was further substantiated when 
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specific miRNAs were found to be overexpressed within diverse tumor types (Lujambio 
et al., 2008, Esquela-Kerscher et al., 2004, Dalmay et al., 2006).  One such miRNA that 
appears to be ubiquitously required for aggressive metastatic potential is miR-21.  
Encoded on chromosome 17q, miR-21 was originally identified as an oncogene in human 
glioblastoma cells (Chan et al., 2005).  Through analysis of RNA isolated from neoplastic 
and non-neoplastic glioma samples, miR-21 was found to be upregulated in gliomas.  
Inhibition of miR-21 expression in cultured glioblastoma cells caused a marked increase 
in apoptosis through activation of the caspase machinery (Chan et al., 2005).  Additional 
evidence for pro-tumorigenic miR-21 was illustrated through microarray analyses that 
showed significant upregulation of miR-21 in all tumors (breast, colon, lung, pancreas, 
prostate, and stomach) irrespective of disease status (Volinia et al., 2006).  Consistent 
with this, the anti-apoptotic protein Bcl-2 was found to be a direct target of miR-21 in 
breast cancer cells and in a xenograft model of breast cancer (Si et al., 2007).  Other 
tumor suppressor targets of miR-21 have been identified including PTEN, which inhibits 
the oncogene PI3K in AKT-mediated cell proliferation (Liu et al., 2013). miR-21 
modulates PTEN levels in lung cancer cells resulting in increased cell growth, migration, 
and invasion (Liu et al., 2013).   
 Several reports have referred to the phenomenon of dependence on a single 
oncogene as “oncogenic addiction” (Weinstein et al., 2002, Jain et al., 2002, and Chin et 
al., 1999).  A landmark in miRNA cancer research was the in vivo demonstration of 
oncogenic addiction in mice conditionally expressing miR-21 (Medina et al., 2010). 
Using Cre recombinase and the Tet-off system, over-expression of miR-21 in 
hematopoietic tissues accelerated pre-B malignant lymphoid-like tumor formation, 
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whereas loss of miR-21 resulted in regression of tumors.  This clearly demonstrates that 
miR-21 is a bona fide oncomiR.  Overexpression of miR-21 in different cancer types 
illustrates the dysregulation and dependence on common miRNA pathways and common 
mRNA targets in the acceleration of tumorigenesis (Krichevsky et al., 2009, Wang et al., 
2009, Zhong et al., 2012, and Reis et al., 2012). 
 Similar to miR-21, the miR-221/222 family encoded on the X chromosome has 
been implicated in several cancer types after initial detection in glioblastoma multiforme 
(GBM) (Ciafre et al., 2005).  Global miRNA expression profiles (miRNome) showed 
increased expression of miR-221/222 in patient tissue samples and GBM cell lines.  
Similar microarray analyses uncovered an increase in miR-221/222 expression in 
papillary thyroid carcinoma, consistent with decreased Kit receptor expression, a gene 
with miR-221/222 binding sites (He et al., 2005).  Also, prostate cancer cells showed 
increased miR-221/222 expression, particularly in highly aggressive PC3 cells (cells 
derived from a distal metastasis) compared to LNCaP cells (slow growing cells derived 
from local lymph-node metastasis) (Galardi et al., 2007).  Overexpression of both 
miRNAs in the slowly growing cell line increased the number of cells entering S-phase.  
For these experiments, targeted inhibition of both miRNAs caused increased expression 
of p27Kip1.  Similarly, treatment of tumor-bearing mice with intravenous injection of 
antisense oligonucleotides against miR-221 resulted in increased survival in mice injected 
with human hepatocellular carcinoma (HCC) (Park et al., 2011).   
 
miRNAs as tumor suppressors 
 Located in a cluster on chromosome 13q14.3, the first described tumor suppressor 
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miRNA was the miR-15/16 family (Calin et al., 2002).  Deletions and translocations in 
this region were found in ~65% of B-cell chronic lymphocytic leukemia (CLL).  An 
initial inverse correlation was recognized between miR-15/16 and the anti-apoptotic 
regulator protein Bcl2, which is over-expressed and a hallmark of CLL (Cimmino et al., 
2005).  Other miR-15/16 family members harbor the same 9 base-pair Bcl2-
complementary sequence, providing evidence for a putative interaction consistent with 
experiments that showed that miR-15/16 post-transcriptionally regulates Bcl2.  Re-
introduction of miR-15/16 in a leukemia-derived cell line lacking both miRNAs resulted 
in strong reduction in Bcl2 levels.  Also, cells transfected with plasmids expressing miR-
15/16 demonstrated increased apoptosis as measured by DNA fragmentation, activation 
of caspases, and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) 
staining of individual cells (Cimmino et al., 2005). 
 Tumor growth relies on genetic alterations coupled with external communication 
to and from the environment.  A critical process for tumor expansion is the establishment 
of stromal progression and the metastatic niche (Whiteside et al., 2008).  Tumor cells 
interact with the extracellular matrix (stroma) and upon metastasis, distant stromal-tumor 
interactions form a niche that facilitates tumor growth.  Distinct cell types configure the 
stromal architecture including fibroblasts that often receive signals (cytokine and 
chemokine) from tumor cells that prime the stroma for tumor growth.  Investigation of 
prostate cancer-stromal interaction showed down-regulation of miR-15/16 in comparison 
to stroma surrounding non-cancerous tissues (Musumeci et al., 2011).  Candidate mRNA 
targets were screened using bioinformatic prediction algorithms and luciferase reporter 
assays and found that the 3’UTR of FGF-2 and FGFR1 can be silenced by miR-15/16, 
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consistent with increased FGF-2 and FGFR1 in prostate cancer (Musumeci et al., 2011).  
Reconstitution of carcinoma-associated fibroblasts with miR-15/16 also showed a 
reduction of FGF-2 and FGFR1.  Lastly, subcutaneous co-injection of prostate cancer 
cells with fibroblasts transduced with miR-15/16 expression vectors dramatically reduced 
tumor growth in immunocompromised mice (Musumeci et al., 2011). Histological 
analyses showed decreased parenchymal invasion, impaired angiogenic behavior, and 
reduction of FGF-2 expression in the stroma.  These experiments show how miRNAs can 
regulate multiple aspects of cancer development including primary tumor growth and 
metastatic spreading. 
 Let-7, the first conserved miRNA discovered in C. elegans, plays a pivotal role in 
regulating animal development and has been implicated in tumorigenesis (Boyerinas et 
al., 2010, and Johnson et al., 2005). In humans, there are 13 let-7 family members 
encoded on 9 different chromosomes (Roush et al., 2008).  Target identification 
experiments support the idea that let-7 negatively regulates Ras, consistent with increased 
levels of oncogenic Ras in lung cancer (Johnson et al., 2005).  Indeed, let-7g reduced 
luciferase activity when the K-Ras 3’UTR was fused to luciferase in mouse lung 
adenocarcinoma cells.  let-7 also repressed the levels of c-Myc using the same reporter 
system.Typically, let-7 loss is due to chromosomal deletions but mutations in the 3’ UTR 
of a let-7 target can also block let-7 function (Mayr et al., 2007).  Chromosomal 
translocations associated with human tumors disrupted repression of the oncogenic 
chromatin-associated let-7 target Hmga2 (High Mobility Group protein A2; Hmga2) by 
deletion of 3' UTR regions targeted by let-7 (Mayr et al., 2007).  Let-7 regulates Hmga2 
by interacting with seven conserved 3’UTR elements.  Expression of truncated Hmga2 
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lacking the let-7 sites induced higher colony formation on soft agar and anchorage-
independent behavior.  Consistent with this, subcutaneous injection of mouse embryonic 
fibroblast cells with full length, wild type Hmga2 produced no tumors, whereas 
fibroblasts harboring mutated let-7 sites or 3' UTR truncations in Hmga2 generated 
tumors at the sites of injections (Mayr et al., 2007).  These data provide in vivo support 
for a tumor suppressor function for let-7 through Hmga2 regulation. 
 One of the most widely studied anti-tumorigenic proteins is p53, the most 
commonly mutated gene in numerous cancers (Finlay et al., 1989).  Originally identified 
as a transcription factor, p53 also acts as a DNA damage response protein and apoptotic 
regulator. Global changes in miRNA levels were examined in p53-deficient mouse 
embryonic fibroblasts and found that miR-34 expression correlates with p53 status (He et 
al., 2007).  Conditional activation of p53 or induction of p53 increased miR-34 levels.  
Analysis of p53 binding showed that p53 occupies specific miR-34 promoter regions.  
Ectopic expression of miR-34 inhibited growth of human primary fibroblast cells, in 
addition to inducing cell cycle arrest in G1 after addition of miR-34 in immortalized 
mouse cells and human tumor cells.  Upregulation of miR-34 also produced changes in 
mRNA expression patterns among a large number of genes implicated in cell 
proliferation including cyclin-E and CDK-4 (He et al., 2007).  These experiments suggest 
a novel mechanism of p53-mediated regulation of cell proliferation through activation of 
miR-34.  miR-34 can therefore be considered a tumor suppressor and indeed, the 
chromosomal region 1p36 encoding miR-34 is frequently deleted in various cancers 
including colon cancer (Di Vinci et al., 1996).  For targets of miR-34, increased SIRT1 
(Silent mating type Information Regulator 1) expression was observed after miR-34a 
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inhibition (Yamakuchi et al., 2008).  SIRT1 is known to regulate apoptosis in response to 
oxidative and genotoxic stress through NAD-dependent deacetylation (reviewed in 
[Bosch-Presegue et al., 2011]).  Cell survival decreased when miR-34a was introduced 
into colon cancer cells but SIRT1 re-expression partially blocked miR-34a-mediated cell 
death.  Interestingly, SIRT1 can deacetylate histones associated with the p53 gene, 
suggesting a positive feedback loop between p53, miR-34a, and SIRT1 (He et al., 2007). 
Besides regulating histone acetylation, miRNAs can also regulate DNA 
methylation.  DNA methylation patterns are frequently altered in cancer (El-Osta et al., 
2003).  The human DNA methyltransferases DNMT3A and -3B are targets of miR-29 
(Fabbri et al., 2007).  The miR-29 family includes miR-29a, miR-19b-1, miR-29b-II, and 
miR-29, located on chromosome 7q32, a region frequently deleted in various leukemias.  
Lung cancer cells transfected with miR-29 showed a global reduction of DNA 
methylation and reduced promoter methylation and therefore expression of the tumor 
suppressor genes FHIT and WWOX (normally hypermethylated and silenced in lung 
cancer) (Fabbri et al., 2007).  In a mantle cell lymphoma model, miR-29 levels were 
found to be controlled by c-Myc (Zhang et al., 2012).  Promoter analysis showed that 
Myc, HDAC3, and EZH2 form a repressive complex to epigenetically repress miR-29 
transcription in Myc-expressing lymphoma cells.  Loss of miR-29 results in upregulation 
of CDK6 and IGF-1R, which are pro-growth genes that promote Myc-associated 
lymphomagenesis (Zhang et al., 2012).  miR-29 loss therefore confers a growth 
advantage, supporting its designation as a tumor suppressor miRNA.       
Small RNAs have also been shown to regulate downstream steps of tumorigenesis 
including angiogenesis and metastasis (Table 2). The versatile role of miRNAs in cancer 
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coupled to their essential roles during animal development make miRNAs attractive 
targets for therapeutic strategies (Fig.3).                                                       
 
 
Table 2:  miRNAs in tumor associated processes  
 
Features of tumorigenesis 
 
Prominent miRNAs 
Oncogenes miR-17-92 cluster, miR-155, miR-372, miR-373, miR-21, 
miR-221/222  
Tumor Suppressor genes miR-15/16, let-7, miR-34, miR-29 
Angiogenesis miR-296, miR-9 
Epithelial-to-Mesenchymal 
transition 
miR-200a/b, miR-205 
Metastasis miR-335, miR-126, miR-206 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
 
Figure 3: Overview of miRNAs in cancer  
miRNAs can be oncogenic or tumor suppressive, highlighting the therapeutic potential of 
these small noncoding RNAs. New therapeutic approaches to cancer treatment now include 
targeting of small RNAs particularly miRNAs. In the future, miRNAs are likely to serve as 
diagnostic, prognostic, and reliable biomarker information during cancer therapy (Andrews, 
O., & Patton, J.G., 2014). 
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Transcriptional Gene Silencing and RNAi 
 One of the pioneering studies in TGS demonstrated de novo methylation on 
corresponding viroid cDNA sequences upon viroid RNA-RNA replication in a transgenic 
Tobacco plant system. Briefly, viroids (plant pathogens) harbor non-coding, highly base-
paired RNAs that are replicated in the nucleus by the host RNA polymerase II. Infection 
with incompetent viroid cDNAs lacking replicative capacity resulted in an unmethylated 
state, leading the authors to propose a model whereby methylases are guided to DNA 
target sequence for methylation via sequence specific RNAs (Wassenegger et al., 1994). 
The upregulation of methyl groups on DNA substrates represents an epigenetic 
modification frequently associated with gene inactivation. More direct evidence for TGS 
and RNAi was shown when dsRNAs targeting the nopaline synthase promoter (NOSpro) 
triggered methylation and transcriptional inactivation of homologous copies of the 
NOSpro in trans. NOSpro dsRNA degradation produced small RNAs ~23 nt in length, 
supporting a connection between TGS and PGTS (Mette et al., 2000).  Cooperation of 
TGS and PTGS was further demonstrated when Brassica napus plants suppressed viral 
gene expression after systemic infection with a DNA virus. Due to shared sequence 
homology between the transgene and virus, co-suppression was mediated via degradation 
of homologous RNA molecules in a post-transcriptional manner. Gene silencing was also 
observed in plants infected with transgenes sharing homology with viral promoter 
sequences, suggesting potential interaction with chromatin to inhibit transcription (Al-
Kaff et al., 1998).  Another investigation observed homology-based, RNA-directed 
methylation associated with silencing following infection of transgenic plants encoding 
GFP with viral RNA vectors with promoter sequences or ORF sequences of GFP (Jones 
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et al., 1999). The above studies supported sequence specific RNA regulation of 
chromatin. In addition to the association of DNA methylation with gene silencing, 
methylation of specific histones also correlates with gene silencing.  
 Extensive studies made in Schizosaccharomyces pombe (S. pombe or fission 
yeast) revealed regulation of repressive histone modification by RNAi. Although S. 
pombe lack DNA methylation, particular regions of the genome is silenced via 
heterochromatin formation. Distinct from euchromatin (active chromatin domains), 
heterochromatic regions are generally characterized by a high density of repeat sequences 
and transposons, with a prominent feature of modified histones that stimulate inactive 
chromatin conformation (Rea et al., 2000, Fischer et al., 2006). In particular, 
trimethylation of lysine 9 on histone H3 is a distinguishing signature. DNA regions 
harboring H3K9me3 are almost always heterochromatic or repressed (Fischer et al., 
2006). In the fission yeast genome, centromeric regions undergo heterochromatic 
silencing (other regions include telomeres and silent mating type loci). Upon deletion of 
RNAi related genes, centromeric silencing is suppressed and H3K9me3 modification is 
reduced. These RNAi mutants also display delocalization of Swi6, which is the fission 
yeast homolog of HP1 (heterochromatin binding protein in higher eukaryotes), that 
specifically recognizes and binds to H3K9me3 (Volpe et al., 2002). Heterochromatin 
assembly was eloquently shown to be regulated by a newly discovered nuclear complex 
containing the RNAi specific protein Ago1 with other binding partners Tas3 and Chp1 (a 
heterochromatin-associated chromodomain protein) in S. pombe (Verdel et al., 2004). 
This complex is referred to as the RNA-induced initiation of transcriptional gene 
silencing or RITS complex with similarity to PTGS associated RISC except for 
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differences in localization and distinct protein components (Creamer K.M., & Partridge, 
J.F., 2011, Denli, A.M., & Hannon, G..J., 2003). Deletion of Dicer leads to loss of small 
RNA species that co-purify with members of the RITS complex from centromeric 
regions, suggesting that these RNAS are Dicer-dependent siRNAs that interact with the 
RITS complex (Verdel et al., 2004).  This directly links RNAi, heterochromatin 
formation, and TGS.  
 
Convergent transcription, RNAi, and heterochromatin   
 Analysis of the fission yeast genome showed that genes arranged in a convergent 
orientation produce overlapping transcripts via convergent transcription (CT) by Pol II. 
Synchronization experiments demonstrated that overlapping dsRNA transcripts are 
specific to the G1 phase of the cell cycle but not G2. During G2, intergenic cohesin acts 
to promote gene-proximal transcription termination and prevents further dsRNA 
production during this phase. Further investigation of G1-specific dsRNA derived from 
convergent genes (CG) showed an induction of localized and transient heterochromatin 
signatures (H3K9me3) and recruitment of Swi6 in an RNAi dependent manner (requiring 
RITS and Dicer activity). siRNAs apparently direct RITS to the homologous convergent 
chromatin region suggesting an autoregulated and cell-cycle dependent mechanism of 
cohesin recruitment to CGs (Gullerova et al., 2008). Interestingly, 80% of RNAi genes 
were discovered to be arranged in a convergent orientation in S.pombe and are down-
regulated in the G1-S phase of the cell cycle by forming transient heterochromatin. 
Repositioning RNAi genes in a tandem orientation at their chromosomal location 
abolished gene silencing during G1-S and generated defects in cell division and 
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morphology (Gullerova et al., 2011).  Transfection of S. pombe with CT plasmids 
harboring ura4 promoter or ORF sequences flanked by convergent nmt1 promoters 
induced silencing of the endogenous ura4 gene in trans. Chromatin immunoprecipitation 
(ChIP) analysis with histone H3K9me3 specific antibodies showed enrichment of 
H3K9me3 at the ura4 locus. Similarly, transfection of Hela cells with CT constructs 
targeting ɣ–actin or TDP-43 genes produced dsRNA and increased H3K9me3 levels, 
supporting a mechanism of RNAi-mediated heterochromatin formation (Gullerova et al., 
2012). Based on these studies, a model is shown that describes how convergent 
transcription mediates gene silencing via RNAi (Fig. 4). 
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Figure 4: Gene silencing via convergent transcription 
Convergent transcription triggers gene silencing. Overlapping transcripts with 
complementary sequence are generated that form dsRNAs that are recognized by nuclear 
Dicer and cleaved to form short siRNA duplexes.  These RNAs become incorporated into 
nuclear effector RITS (RNA-Induced Transcriptional Silencing) complexes. The guide 
siRNAs direct RITS to the convergent chromatin location, leading to recruitment of 
methlytransferases and subsequent increases in H3K9 trimethylation. As a result, genes are 
silenced at the level of transcription (model adapted from Nick Proudfoot studies) (Gullerova 
et al., 2012). 
 
 
Zebrafish model system   
 Zebrafish (Danio rerio) has emerged as a powerful model organism for the study 
of vertebrate development and disease. Zebrafish studies began when George Streisinger 
initiated the application of mutational analysis to study vertebrate embryonic 
development during the 1960s. As the organism began to be studied by others (Charles 
Kimmel, Christiane Nüsslein-Volhard, Marc Fishman, Wolfgang Driever, Monte 
Westerfield, and Judith Eisen) during the 1980s, cell lineage and mapping information 
became established. By the 1990s, forward genetic screens were used in zebrafish to 
identify embryonic lethal mutations and extensive investigation focused on stages of 
zebrafish development began (Grunwald, D.J., & Eisen, J.S., 2002). As an organism that 
fertilizes externally and produces optically transparent embryos with high fecundity, 
zebrafish were ideal for visually studying development.  A landmark publication fully 
described zebrafish development defining seven broad periods of embryogenesis – the 
zygote, cleavage, blastula, gastrula, segmentation, pharyngula, and hatching periods. 
These stages were based on morphological features of zebrafish embryos under 
observation with dissecting stereomicroscope (Kimmel et al., 1995). Genetic studies and 
cloning of mutants identified genes involved in early patterning of the zebrafish embryo. 
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Within the last decade, zebrafish has also been used to model human disease including 
hematopoietic disorders, cardiovascular disorders, and kidney disorders (Dooley, K., & 
Zon, L.I., 2000). Large scale sequencing of the zebrafish genome identified over 26,000 
protein-coding genes and comparison to the human reference genome showed that ~70% 
of human genes have at least one zebrafish orthologue (Howe et al., 2013). Zebrafish also 
express small noncoding RNAs – miRNAs - (Weinholds et al., 2005, Thatcher et al., 
2008, Wei et al., 2012).  
 
 
Gene silencing tools in zebrafish 
 Zebrafish has been used to study reverse genetics to determine gene function. The 
most widely used strategy to knockdown genes post-transcriptionally in this organism are 
antisense morpholinos (MO). MOs are chemically modified oligonucleotides that inhibit 
RNA by steric hindrance and by blocking translation of mRNA.  The unique structure of 
MOs derives from the use of morpholine rings to replace the ribose backone of nucleic 
acids (Summerton, J., & Weller, D., 1997) which confer resistance to nuclease digestion 
and enhanced affinity for binding to complementary RNA sequences (Summerton, J., 
1999). The first study that paved the way for using MOs in zebrafish showed specfic 
silencing of GFP and the uroporphyrinogen decarboxylase gene, which generated 
embyos mimicking a human disease (hepatoerythropoietic porphria) (Nasevicius, A., & 
Ekker, S.C., 2000). While the MOs have proven quite useful, several disadvantages have 
been uncovered including non-specific effects, limited duration, and toxicity. Large 
mutagnesis screens either by retrovirus mediated insertions or chemical exposure to ENU 
(N-ethyl-N-nitrosourea) have also been used to mutate zebrafish genes. Disadvantages of 
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these mutagenesis screens include the labor-intensive step of mapping insertion sites and 
the generation of large mutant libraries to identify desired mutations. Silencing of genes 
in zebrafish has also been accomplished using a gene targeting approach by site-specific 
or programmable genome modifications. These include zinc-finger nucleases (ZFNs), 
transcription activator-like effector nucleases (TALENs), and the CRISPR-Cas sytem 
(clustered regulatory interspaced short palindromic repeat). The common features of site-
specific ZFNs and TALENs are the chimeric nature of the nucleases which harbor 
sequence-specific DNA- binding modules linked to a nonspecific DNA cleavage domain. 
Genome editing by ZFNs and TALENs is achieved by induction of double stranded 
breaks in the DNA and activation of DNA damage response pathways that utilize either 
error-prone nonhomologous end joining or homology-directed repair at specific genomic 
locations to repair the damage. Successful targeting of zebrafish genes using  ZFN (gol 
and ntl) induced somatic loss-of-function phenotypes with embryos displaying decreased 
pigmentation or truncated body axis with no tail, respectively (Doyon et al., 2008). Using 
a modified TALEN systen (GoldyTALEN) with single-stranded DNA oligonucleotides as 
donor templates, successful homology-directed repair was achieved in zebrafish (Bedell 
et al., 2012). Despite the successes of ZFNs and TALENs, limitations and drawbacks 
include off-target activity, cellular toxicity, and high cost (Gaj et al., 2013). Unlike ZFNs 
and TALENs, the CRISPR/Cas system uses small RNAs to guide DNA endonucleases to 
specific sites which can differ by changing the RNA guide sequence. The CRISPR 
nuclease system has been used to silence genes in zebrafish embryos with high efficiency 
(Hwang et al., 2013) and to knock-in via homology-independent DNA repair (Auer et al., 
2013). Improved designs to the system include a chimeric guide RNA (gRNA) consisting 
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of a fused CRISPR RNA and transacting RNA sequences and purified Cas9 
(endonuclease) that induce site-specific DNA double stranded breaks. One report has 
demonstrated robust silencing with the improved chimeric guide when targeting a 
reporter gene and four endogenous loci. Within their system, high mutagenesis rates (75-
99%) were observed in zebrafish (Jao et al., 2013). Although these genome editing tools 
have demonstrated high efficiency in silencing, however, the subsequent mutation is 
irreversible. Current studies are working to make CRISPR technology temporally and 
spatially regulated but so far, there’s none at hand. Thus, an effective gene silencing tool 
that is easily regulated both temporally and spatially is missing in zebrafish.  
 The RNAi pathway has been explored in zebrafish in a PTGS context and yielded 
inconsistent results.  While few studies showed specific gene silencing, other reports 
showed nonspecific phenotypes following dsRNA injection into zebrafish embryos. In 
order to understand the feasibility and functionality of RNAi, a collaborative effort was 
made to investigate RNAi using a TGS approach. Using the Tol2 vector transfer system, 
Diana Cha generated convergent plasmid constructs targeting mCherry protein, and we 
observed silencing in embryos. I optimized and used chromatin immunoprecipitation 
methods to determine that suppression of mCherry was mediated by a histone 
modification associated with silencing–H3K9me3. I detected enrichment of H3K9me3 on 
convergent chromatin from transient transgenics and a significant increase of H3K9me3 
in F1 and F2 embryos. Convergent transcription was also used to suppress transcription 
of One Eyed Pinhead, producing embryos with similar mutant phenotypes. To analyze the 
ability to silence noncoding RNAs, I generated convergent plasmid constructs targeting 
miR-27a/b family members, which were previously shown to be required for proper 
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craniofacial development.  I showed that injection of convergent plasmids phenocopied 
miR-27a/b morphants using cartilage specific staining in a specific population of 
embryos. 
 
Summary 
 
 Small RNAs including miRNAs and siRNAs play important roles in gene 
regulation in diverse species. Through interaction with mRNA targets, miRNAs control 
developmental events and normal cellular behavior. The discovery of miRNAs in 
diseases including cancer highlight the importance of investigating miRNAs during 
aberrant cellular behavior and exploring them for future therapeutic strategies. While 
great progress has been made in understanding siRNA and miRNA function at the post-
transcription level, there are still questions regarding roles for small RNAs at the level of 
transcription. Since most of the studies of RNAi-based TGS occur in plants and fission 
yeast, it is not entirely clear how applicable these mechanisms will apply in higher 
vertebrates.  The work in this thesis explores TGS in a higher vertebrate model- the 
zebrafish. 
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Abstract 
 RNAi based strategies to induce gene silencing are commonly employed in 
numerous model organisms but have not been extensively used in zebrafish.  We found 
that introduction of transgenes containing convergent transcription units in zebrafish 
embryos induced stable transcriptional gene silencing (TGS) in cis and trans for reporter 
(mCherry) and endogenous (One-Eyed Pinhead (OEP) and miR-27a/b) genes.  
Convergent transcription enabled detection of both sense and antisense transcripts and 
silencing was suppressed upon Dicer knockdown, indicating processing of double 
stranded RNA.  By ChIP analyses, increased silencing was accompanied by enrichment 
of the heterochromatin mark H3K9me3 in the two convergently arranged promoters and 
in the intervening reading frame.  Our work demonstrates that convergent transcription 
can induce gene silencing in zebrafish providing another tool to create specific temporal 
and spatial control of gene expression.  
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Introduction  
 Zebrafish is a powerful model vertebrate organism to elucidate mechanisms 
regulating development and disease (Lieschke et al., 2007).  The availability of large 
numbers of external, optically transparent developing embryos, combined with genetics 
and imaging, have provided exceptionally useful tools to study development and as 
powerful animal models of numerous human diseases.  However, a critical missing tool is 
a simple, straightforward way to post-transcriptionally knock down genes in a sequence 
specific manner, especially at later stages of development.  Recent reports have described 
the possibility that shRNA approaches might be useful for temporal and spatial 
knockdown of genes in zebrafish (Dong et al., 2013, De Rienzo et al., 2012).  More 
commonly, antisense morpholinos have been used to knockdown gene expression during 
early development and have proven quite useful but with important caveats related to 
toxicity, limited duration, and potential off-target effects (Bill et al., 2009).  Here, we 
describe a novel RNA interference (RNAi) mediated mechanism to silence gene 
expression in zebrafish.  First discovered in C. elegans, the discovery of RNAi ushered in 
a new era of reverse genetics allowing sequence specific knockdown of genes in multiple 
model organisms (Fire et al., 1998). As an umbrella term, RNAi encompasses a number 
of gene regulatory mechanisms that ultimately depend on the production of small 
dsRNAs.  Post-transcriptional gene silencing (PTGS) methods utilize small RNAs 
derived either from endogenous genes (miRNAs) or from exogenously delivered small 
interfering RNAs (siRNAs) (Hammond et al., 2001).  Primary transcripts encoding 
miRNAs are initially processed to precursor miRNAs (pre-miRNAs) in the nucleus by 
Drosha (Lee et al., 2003) followed by a second processing step in the cytoplasm by the 
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enzyme Dicer that produces mature 21-23 nucleotide dsRNAs (Bernstein et al., 2001).  
Following Dicer processing, one of the strands is incorporated into a multi-component 
complex called the RNA Induced Silencing Complex (RISC) containing Argonaute 
proteins (Cenik et al., 2011). Complementary base pairing then determines the fate of 
targeted mRNAs.  Perfect pairing (siRNAs) results in mRNA cleavage whereas imperfect 
pairing (miRNAs) results in translational repression, deadenylation, and subsequent 
degradation of target mRNAs (Djuranovic et al., 2012). 
 Despite the fact that the zebrafish genome encodes Dicer, Drosha, and RISC 
components (Flynt et al., 2009), siRNA-mediated gene knockdown remains controversial 
with the limited number of reports claiming successful knockdown countered by results 
suggesting that the effects are entirely nonspecific (Wargelius et al., 1999, Acosta et al., 
2005, Zhao et al., 2008, Li et al., 2000, Oates et al., 2000, Mangos et al., 2001, Gruber et 
al., 2005, Wang et al., 2010).  These conflicting reports account for the fact that 
morpholino-mediated knockdown is prevalent in zebrafish, especially during early 
development.  Given the limitations of morpholinos, we sought to determine whether 
RNAi-mediated chromatin silencing could silence genes in zebrafish.  Transcriptional 
gene silencing (TGS) directed by small RNAs has been widely reported and recent work 
has raised the possibility that similar mechanisms may apply in higher eukaryotes 
(Martienssen et al., 2005, Sabin et al., 2013, and Moazed, D., 2009).  While examining 
transcription termination in Schizosaccharomyces pombe, the Proudfoot lab discovered 
that overlapping transcripts derived from genes organized in a convergent manner can 
generate dsRNAs that activate nuclear RNAi leading to histone methylation, recruitment 
of cohesin, and silencing of the convergent genes (Gullerova, M. & Proudfoot, N.J., 
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2008).  The methylation marks that regulate chromatin are removed during G2 enabling 
transient production of overlapping RNAs that then silence the genes during G1/S.  A 
number of genes encoding RNAi components in the S. pombe genome are arranged in a 
convergent manner enabling autoregulation (Gullerova et al., 2011).  Interestingly, the 
same mechanism can silence genes in mammalian cells (Gullerova, M. & Proudfoot, N.J., 
2012, Calero-Nieto et al., 2010).  Based on the presence of functional RNAi genes in the 
zebrafish genome, we hypothesized that convergent transcription could be used to 
specifically silence genes via a comparable mechanism.  Our data demonstrate that 
transgenic zebrafish harboring convergently arranged genes generate dsRNAs that direct 
chromatin silencing of both reporter constructs and endogenous genes.  Silencing leads to 
H3K9me3 deposition and can be suppressed by Dicer knockdown, consistent with the S. 
pombe data.  This paper is the first paper to demonstrate that RNAi-mediated chromatin 
silencing is possible in zebrafish with the ability to precisely control spatial and temporal 
gene expression in embryos and adult zebrafish. 
 
Results 
Convergent transcription induces gene silencing in zebrafish. 
 To determine if we could trigger RNAi-mediated gene silencing in zebrafish via 
convergent transcription, we created plasmids with transcriptional promoters arranged in 
either a convergent (CT) or nonconvergent (non-CT) manner.  The experimental setup 
included insertion of open reading frame (ORF) sequences between the two promoters 
with no 5' or 3' UTR sequences.  For proof of principle, we first targeted mCherry for 
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rapid visualization of silencing.  For the non-CT mCherry construct, the full length 
zebrafish β-actin promoter was inserted upstream of the mCherry open reading frame 
(ORF).  The CT mCherry construct harbored a β-actin promoter at the 5’ end and an 
inverted CMV promoter at the 3’ end (Fig. 5A).  Transient transgenic animals were 
created by co-injecting embryos at the 1-2 cell stage with the non-CT mCherry construct 
and Tol2 transposase mRNA (Kawakami, K., 2009).  As a marker of transgenesis, the 
cardiac myosin light chain promoter (cmlc2) was fused to GFP driving fluorescent 
expression in the heart (Kwan et al., 2007).  As expected, transgenic animals containing 
the non-CT mCherry construct displayed robust expression of mCherry throughout the 
entire developing embryo (Fig. 5B).  In contrast, there was a striking absence of mCherry 
in transgenic animals created by injection of the CT mCherry construct (Fig. 5B).  Except 
for a few small puncta and some yolk autofluorescence, the levels of mCherry were 
dramatically reduced to near zero.  The lack of mCherry was not due to the absence of the 
transgene as readily detectable levels of heart GFP were observed (Fig. 5B).  Silencing 
was robust across multiple injections with undetectable levels of mCherry in greater than 
92% of the transgenic CT-mCherry embryos.  Nearly ~100% of non-CT mCherry 
transgenic embryos broadly expressed mCherry.  Importantly, crossing of founders to 
generate F1 and F2 generations showed that silencing of mCherry is stable and continues 
to be maintained.   
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Figure 5. Convergent silencing of mCherry. 
(A) Non-CT and CT constructs were designed using the Tol2 transgenesis system with  
the β-actin promoter driving sense transcription and an inverted CMV promoter driving 
antisense transcription of the mCherry open reading frame (see Supplement for maps and 
sequence information).  All constructs harbored heart-specific GFP (cmlc2-GFP) which 
enabled identification of transgenic embryos.  (B) Widespread expression of mCherry was 
observed in non-CT embryos (386 out of 386 transgenic embryos), whereas near complete 
loss of mCherry was observed in CT-mCherry embryos at 2dpf (370 out of 402 transgenic 
embryos). 
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Convergent transcription produces dsRNA and silencing is suppressed upon 
knockdown of Dicer 
 
 In order to determine whether the mechanism of mCherry silencing was as 
predicted based on convergent silencing in S. pombe (Gullerova, M. & Proudfoot, N.J., 
2012), we designed primers to amplify sense and antisense mCherry transcripts.  We 
reasoned that convergent transcription should produce both sense and antisense 
transcripts.  As expected, the levels of sense mCherry transcripts in non-CT F2 embryos 
were abundant, 30-fold more than the levels detected in CT-mCherry animals, whereas 
the levels of antisense transcripts were at or just barely above background levels.  In 
contrast, RNA isolation and qPCR analyses from F2 embryos derived from multiple F1s 
confirmed elevated levels of both sense and antisense mCherry transcripts with slight 
variation between lines (Fig. 6A).  These data argue against the idea that the loss of 
mCherry is due to simple steric interference from colliding convergent polymerases. 
 If the mechanism of silencing that we observe is an RNAi-mediated event, as 
suggested by the presence of sense and antisense transcripts, it should require Dicer 
activity to cleave dsRNA for packaging into RNA Induced Silencing Complexes (Castel 
et al., 2013).  To test whether decreased levels of Dicer would suppress CT-mCherry 
silencing, we used antisense morpholinos to knockdown Dicer.  Compared to scrambled 
control morpholinos, Dicer morphants displayed an increase in mCherry levels (Fig. 6B).  
Not only could we detect increased mCherry transcript levels after Dicer knockdown, we 
also observed increased mCherry protein levels using Western blots (Fig. 6C; full gel in  
Fig. 7).  Taken together, these results indicate that silencing of mCherry is suppressed 
upon Dicer knockdown and consistent with the formation of dsRNA from sense and 
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antisense transcripts.  The fact that the levels of suppression are not complete is expected 
and is likely due to the efficiency of Dicer knockdown but could also indicate a 
requirement for other components involved in nuclear RNAi mediated silencing. 
 
RNAi-mediated chromatin modification 
 To further elucidate the mechanism of sustained mCherry gene suppression, we 
tested whether increased levels of H3K9me3 could be detected in the convergent 
promoters and within the mCherry open reading frame.  Increased levels of H3K9me3 
would be indicative of heterochromatin formation in vivo and would be further 
confirmation that convergent silencing in zebrafish utilizes a similar mechanism as 
proposed in S. pombe.  To test for histone modification, we utilized formaldehyde-based 
in vivo cross-linking/immunoprecipitation (Chromatin immunoprecipitation; ChIP) with 
antibodies against H3K9me3.  Chromatin was isolated from non-CT and CT mCherry 
injected embryos and specific primers were then used to amplify the border region 
between the β-actin promoter and the mCherry ORF, within the mCherry ORF, and in the 
inverted CMV promoter.  We performed ChIP on F1 and F2 embryos (Figs. 8 9) and 
observed enrichment of H3K9me3 on convergent mCherry promoters and the mCherry 
ORF.  Some embryos demonstrated significant enrichment of H3K9me3 after 
normalizing the histone silencing signal to the IgG negative control signal (Figs. 8 and 
9A). As shown in Fig. 6D in F2 embryos, compared to the IgG control, we detected a 16-
fold enrichment for H3K9me3 modified DNA on the β-actin promoter-mCherry border, a 
15 fold enrichment within the mCherry ORF, and a 13 fold enrichment within the 
inverted CMV promoter.  As an additional control, we examined the levels of H3K9me3 
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on an unrelated, active zebrafish gene, the flk-1 promoter (Jin et al., 2005).  We were not 
able to detect any enrichment for H3K9me3 in the flk-1 promoter (data not shown).  
Combining experiments to detect sense and antisense transcripts, suppression upon Dicer 
knockdown, and H3K9me3 marks, our data are consistent with a model of RNAi-
mediated heterochromatin silencing in zebrafish.   
Figure 6. mCherry silencing is Dicer dependent and results in increased levels of 
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H3K9me3 chromatin modification.  
(A) Detection of sense and antisense mCherry transcripts via qPCR analysis in F2 embryos 
from 3 different CT-mCherry F1 lines.  (B) Increased mCherry sense mRNA levels upon co-
injection of a Dicer MO compared to control (ctrl) MO injected transient transgenics at 
54hpf.  (C) Rescue of mCherry protein levels upon co-injection of Dicer MO.  Protein lysates 
were prepared from embryos as in (B) and Western blots were prepared with antibodies 
against mCherry and α-tubulin.  The full gel is shown in Fig. 7.  For comparison, protein 
levels in a non-CT embryo are as shown.  (D) ChIP-qPCR showing significant enrichment of 
H3K9me3 levels on convergent chromatin from CT-mCherry F2 embryos (F1 line 9119).  
Enrichment was determined compared to negative IgG control at 5dpf.  ChIP values and 
standard deviations are shown from three independent biological experiments. ***p<.001 
based on unpaired, two-tailed distribution Student’s t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Rescue of mCherry by Dicer knockdown. 
The full Western blot from Figure 6 is shown.  The blot was cut in half to probe for either α-
tubulin or mCherry.  Lanes 1 and 2 correspond to UIC embryos from 2 separate clutches.  
Lane 3 (empty). Lane 4: CT-mCherry injected embryos.  Lane 5: CT-mCherry + 2.5ng Dicer 
MO. Lane 6: non-CT mCherry injected embryos.  Both bands correspond to α-tubulin.  Band 
at ~27kDa corresponds to mCherry.  The dye front is as indicated. 
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Figure 8. Enrichment of H3K9me3 in F1 CT-mCherry embryos. 
 (A-C) ChIP-qPCR indicating increased H3K9me3 occupancy on convergent chromatin in F1 
embryos from 3 different male founders mated with wild type AB females at 5dpf.  ChIP 
values and standard deviations are from three independent experiments.  *(p<.05) and 
**(p<.01) based on unpaired, two-tailed distribution Student’s t-test. 
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Figure 9. Enrichment of H3K9me3 in F2 CT-mCherry embryos.       
(A-B) ChIP-qPCR indicating increased H3K9me3 occupancy on convergent chromatin in F2 CT-
mCherry embryos from 2 different F1 lines mated with either wild type AB fish or siblings at 
5dpf.  ChIP values and standard deviations are from three independent experiments.  *(p <.05) 
and **(p<.01) based on unpaired, two-tailed distribution Student’s t-test.  Rescue experiments 
were performed to determine whether knockdown of Dicer would decrease the levels of 
H3K9me3 but because our ChIP experiments were optimized for 5 dpf, the effects were not 
robust, likely due to the half life of the Dicer morpholino.  
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Convergent silencing in trans: One Eyed Pinhead 
 To address the ability of convergent transcription to silence genes in trans, we 
generated a convergent construct targeting the endogenous One-Eyed Pinhead (OEP) 
gene (Schier et al., 1997) (Fig. 10A).  We chose this gene because the OEP phenotype is 
well characterized and easy to score.  As shown in Fig. 10B-G and quantified in Fig. 
10H, 43% of transient transgenic animals injected with CT-OEP displayed cyclopia, 
strong ventral curvature of the body axis, and a reduced/misshapen notochord, consistent 
with OEP mutants and morpholino knockdown of OEP (Schier et al., 1997, Nasevicius, 
A. & Ekker, S.C., 2000).  More severe defects were observed in 12% of the embryos with 
eyeless, headless, or severely reduced body axis.   Interestingly, the more severe 
phenotypes resemble those observed with high concentrations of OEP MOs which were 
proposed to be due to the loss of both maternal and zygotic OEP expression (Nasevicius, 
A. & Ekker, S.C., 2000).  In our experiments, the more severe effects would not be due to 
destruction of maternal transcripts but are consistent with increased silencing of the 
endogenous OEP gene.  
 To test whether silencing of OEP in trans could be suppressed by knockdown of 
Dicer, embryos were co-injected with the Dicer MO.  As shown in Fig. 10I, knockdown 
of Dicer resulted in a substantial decrease in the number of embryos displaying the OEP 
phenotype from 43% to 15%.  The OEP experiments suggest that convergent silencing 
can be used to silence endogenous zebrafish genes in trans.  
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Figure 10. Silencing of One Eyed Pinhead 
Convergent silencing of the zebrafish One Eyed Pinhead (OEP) gene with the β-actin 
promoter driving sense transcription and an inverted CMV promoter driving antisense 
transcription.  The OEP open reading frame was directly cloned between the two promoters.  
(B-G) Compared to uninjected control embryos (UICs), CT-OEP injected embryos 
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phenocopied OEP mutants with curved body axis, cyclopia (black arrow in C), and reduced 
notochord (red arrows in F compared to G).  In 12% of the CT-OEP embryos, we observed a 
more severe phenotype with complete loss of eye development (red asterisk in E).  (H) Graph 
showing % transient transgenics showing WT, classic OEP, or more severe phenotypes.  
n=167. (I). Silencing of OEP is Dicer dependent.  Embryos were injected as indicated in the 
absence or presence of Dicer MO or a control mismatch morpholino.  **p<0.005.  
  
 
Convergent silencing of miR-27a/b 
To further demonstrate the utility of targeting endogenous genes with convergent 
transcription, we decided to target a miRNA gene.  We chose miR-27a/b because 
morpholino and CRISPR knockdown of miR-27a/b results in dramatic craniofacial 
defects and impairment of pectoral fin outgrowth that can be readily detected both 
visually, and by staining extracellular matrix (ECM) and cartilage with alcian blue (Kara 
et al, manuscript in preparation).  Tol2 based CT and non-CT constructs were generated 
with identical convergently arranged zebrafish Ubiquitin promoters flanking a fusion of 
DNA sequences encoding the precursors of both miR-27a and miR-27b (Fig. 12A).  We 
chose to use the Ubiquitin promoter as a means to test the utility of multiple promoters 
and to begin to address questions related to differential promoter strength.  Although the 
frequency of the defect was lower than what we observed with mCherry and OEP 
convergent silencing, we found that transgenic animals containing the CT construct 
showed a nearly identical phenotype to that produced upon morpholino knockdown ( Fig. 
11) of miR-27a/b (Fig. 12B).  This included loss of craniofacial structures, loss of upper 
and lower jaws, and impaired pectoral fin outgrowth.  Only ~8-10% of transgenic 
animals displayed the phenotype but this was significantly higher than that compared to 
DICs where much less than1% of the embryos showed some form of jaw defect or slight 
changes in alcian blue staining patterns (Fig. 12C).  While the reasons for less efficient 
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silencing of the miR-27a/b genes are not clear, the results indicate that convergent 
transcription can be used to silence noncoding RNAs in trans. 
 
 
 
 
 
 
 
 
Figure 11. miR-27a/b morphants.                                         
Uninjected (UIC) embryos or embryos injected with morpholinos against miR-27a/b were 
stained with alcian blue at 4dpf to detect extracellular matrix and developing cartilage. 
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Figure 12. Silencing of miR-27a/b. 
(A) Convergent silencing of the miR-27a/b genes with ubiquitin promoters driving both sense 
and antisense transcription.  A synthetic DNA sequence encompassing precursor sequences 
for both miR-27a and miR-27b were directly cloned between the two promoters. (B) 
Compared to control embryos injected with dye only (DIC), lateral and ventral views show 
that CT-miR-27a/b injected embryos phenocopy miR-27a/b morphants (see Supplemental 
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Figure 4) with defects in pharyngeal arch morphogenesis, craniofacial defects, and inhibition 
of pectoral fin outgrowth as shown by decreased staining of ECM (cartilage) with alcian 
blue.  (C) Compared to DICs, craniofacial defects observed with alcian blue staining were 
observed in 8-9.5% of CT-miR-27a/b embryos using two different plasmid clones of the 
construct in (A). n=191 for DIC, n=458 for CT-miR-27a/b clone 1, and n=272 for CT-miR-
27a/b clone 2.  All images are at 4dpf. 
 
 
Discussion 
Using convergent transcription to induce nuclear RNAi-mediated gene silencing, 
we achieved targeted silencing of exogenous mCherry and endogenous mRNA (OEP) 
and miRNA (miR-27a/b) encoding genes.  This paper is the first to show that nuclear 
RNAi mediated gene silencing can be used in zebrafish to trigger heterochromatin 
formation.  The mechanism of silencing in zebrafish is hypothesized to follow that 
described in fission yeast, which is supported by two sets of experiments.  First, Dicer 
knockdown suppressed transcriptional gene suppression of both mCherry and OEP, 
suggesting that long dsRNAs derived from the convergent promoters fail to be efficiently 
processed and thereby unable to elicit TGS.  Second, our ChIP analyses showed 
increased H3K9me3 levels coincident with silencing. Enrichment of H3K9me3 was 
maintained and became even more pronounced from generation to generation, with 
greatest H3K9me3 occupancy observed in F2 generations. These novel findings 
demonstrate that convergent transcription can trigger nuclear RNAi pathways to allow 
reverse genetics in zebrafish.  With multiple tools available to regulate transcription in 
zebrafish, precise spatial and temporal control of gene expression is possible using 
convergent transcription (Halpern et al., 2008, Bai et al., 2009). 
 Currently, the most common method to knockdown genes in zebrafish utilizes 
antisense morpholinos to block mRNA translation, inhibit pre-mRNA splicing, or 
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interfere with miRNA function (Nasevicius, A. & Ekker, S.C., 2000, Flynt et al., 2007). 
Despite ongoing work, the use of RNAi in zebrafish remains elusive (Kelly, A. & 
Hurlstone, A.F., 2011).  Reports of successful knockdown via RNAi have been countered 
by reports of broad nonspecificity.  Recently, shRNA expression vectors have been 
generated to produce siRNAs mimicking miRNA pathways (Dong et al., 2013, De 
Rienzo et al, 2012, Dong et al., 2009) but it remains to be determined how useful or 
efficient these methods will be in generating stable knockdown lines.  For mCherry 
knockdown, we observed stable, ongoing silencing.  However, we also observed gene 
dependent differences in efficiency.  Silencing of mCherry was greater than 92%, 
silencing of OEP was approximately 50%, and silencing of miR-27a/b was the least 
efficient at ~9%.  Differences in efficiency can be due to numerous causes with obvious 
challenges for silencing high copy genes with stable mRNAs.  Additionally, as more is 
learned about how small RNAs direct sequence specific silencing, we will likely learn 
more about how chromatin is altered and how chromosome location and positioning 
might affect silencing.  Nevertheless, the ability to generate stable convergent lines 
creates an advantage over standard morpholinos that can lack precise spatial and temporal 
control, not to mention possible off target and nonspecific effects.  As we develop this 
strategy further, we will examine the expansion of heterochromatin marks on different 
promoters and ORFs as well as discern the exact requirements for the size and abundance 
of the convergent transcripts to gain a better understanding of the mechanism and 
functional relevance of convergent silencing in zebrafish.   
 In addition to variable efficiencies of silencing in mCherry, OEP and miR-27a/b, 
we also found that some genes were not able to be targeted for silencing.  Convergent 
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constructs targeting different pigment genes (tyrosinase, golden, sandy) showed a delay 
or only very limited silencing of pigment expression, provided the embryos survived, 
especially for tyrosinase.  Despite changes in the use of different strength promoters or 
different length ORF sequences in the convergent constructs, we were never able to 
generate non-pigmented embryos.  A potential explanation for the lack of silencing with 
the CT-pigment constructs could be due to limiting levels of Dicer since Dicer over-
expression was shown to promote primary siRNA generation in a genome wide 
dependent manner in S. pombe (Yu et al., 2014).  Further, sequence context and 
chromosomal position can also inhibit siRNA-mediated heterochromatin formation (Yu 
et al., 2014).  Lastly, even though we have focused extensively on the role of Dicer, other 
components of the RNAi pathway, such as Argonaute proteins (Lund et al., 2011) are 
likely required and might be limiting for nuclear RNAi.  Future work will be necessary to 
answer such questions as well as positional and sequence-dependent effects on 
convergent gene silencing.  Nevertheless, our results demonstrate that RNAi-mediated 
heterochromatin formation can be used to silence genes in zebrafish.   
 Tools to efficiently knockdown gene expression or generate gene knockouts in 
zebrafish are rapidly evolving with CRISPR mediated gene editing rapidly becoming a 
common technique in zebrafish (Jao et al., 2013).  In our hands, knockdown of miR-27a/b 
is most efficient with antisense morpholinos, followed by CRISPR knockout, followed by 
convergent silencing.  As discussed above, morpholino based knockdowns suffer from 
temporal and spatial limitations.  Although spatial restrictions can be overcome using 
CRISPR technology, temporal and reversible strategies are still lacking and it may not 
always be desirable to create irreversible genetic mutations.  For some applications, 
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convergent silencing could prove useful, especially with tissue specific and inducible 
promoters that can be further used to control temporal and spatial production of dsRNA. 
 
Material and Methods 
Ethics Statement 
 All zebrafish experiments and methods were carried out in accordance with the 
approved guidelines from the Vanderbilt Institutional Animal Care and Use Committee 
(IACUC) under protocol M-09-398.   
 
Plasmid Constructs 
 Convergent vectors were created by inserting ORF sequences directly between 
convergent promoters with no 5' or 3' UTR sequences.  For miR-27a/b, a region 
encompassing the precursor sequence for both miRNAs was inserted directly between 
convergent Ubiquitin promoters (see below).  All plasmid constructs were created using 
Gateway technology (Kwan et al., 2007) as shown in Figure 13.  Destination vectors 
were created in the pDEST2G2 backbone by Gateway LR Clonase II reactions 
(Invitrogen) using the following vectors: 
For non-CT-mCherry: p5E-β-Actin, pME-mCherry, p3E-pA. CT-mCherry: p5E-β-Actin, 
pME-mCherry, p3E-iCMV. non-CT OEP: p5E-β-Actin, pME-OEP, p3E-pA. CT-OEP: 
p5E-β-actin or p5E-CMV, pME-OEP, p3E-iCMV or p3E-iβ-Actin.  
Inverted promoters were inserted into p3E (3’-entry vectors) to transcribe the antisense 
strand of target genes.  P3E-iCMV, p3E-iβActin and p3E-Ubi promoter sequences were 
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PCR amplified with Phusion polymerase (NEB) from p5E-CMV/SP6, p5E-β-Actin (Tol2 
Kit) and p5E-Ubi (a kind gift from Dr. Josh Gamse), respectively.  Forward and reverse 
primers were flanked by attB2 and attB3 sites (lowercase, respectively:  
Table 3. List of inverted promoter primers 
iCMV Forward- 5’ggggacagctttcttgtacaaagtggaTCACCTAAATCAAGCTTGCTC 3’ 
 
iCMV Reverse - 5’ ggggacaactttgtataataaagttgccAAGGCCTCTTCGC 3’ 
 
iβ-Actin Forward- 
5’  ggggacagctttcttgtacaaagtggaGGATCCGGCTGAACTGTAAAAGAAAG 
3’ 
iβ-Actin Reverse- 5’ ggggacaactttgtataataaagttgccggtaccAATTCCAGTTTGAAG 3’ 
 
iUbi Forward –  
5’ ggggacagctttcttgtacaaagtggaGGATCCCTGTAAACAAATTCAAAG 3’ 
 
iUbi Reverse – ggggacaactttgtataataaagttgCCCTCGAGACCAGCAAAGTTCTAG 
 
 
 
pME-OEP:  OEP cDNAs were generated using 500ng of total RNA from sphere stage 
wild type embryos using Superscript II reverse transcriptase (Invitrogen).  Forward and 
reverse primers flanked by attB1 and attB2 sites (lowercase) were then used for PCR 
amplification:  
 
F- 5’ ggggacaagtttgtacaaaaaagcaggctTGCCACCATGACGAGTCAACTGTTCG 3’ 
R- 5’ ggggaccactttgtacaagaaagctgggtGCATACGGAGCGTTACAGTACA 3’ 
 
pME-miR27a/b: The following sequence was ordered from GeneArt (Life Technologies) 
containing a fusion of precursor sequences for miR-27a and miR-27b: 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGGGCCAATAGCTAATATGGCC
AATGATTTggagagcaTCTGGATATGATGTCTGCTGAAGTTTCGTGAGGTGCAGG
ACTTAGCTCACTCTGTGAACAGATCTCGGATATCCTATGTTCACAGTGGCTAA
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GTTCCGCTCCTCTGAGGCCCACACTCGAAATCAGCCAGGaggtgagaacacaaacatgac
GCGGCCGCTCTTTTCTAGCAGGTGCAGAGCTTAGCTGATTGGTGAACAGTGAT
TGAACTCTTTGTTCACAGTGGCTAAGTTCTGCATCTGAGGAGAGGACAGTGTA
CCCAGCTTTCTTGTACAAAGTGGTCCCC 
 
BP reactions (Invitrogen) were performed to recombine the PCR amplicons into entry 
vectors following the manufacturers protocol. All entry vectors were sequence verified 
with M13 F and M13 (-21) R primers.  The maps of the various vectors are shown in 
Figure 13-15.  
 
Figure 13. Model of Gateway Vector Transfer  
Convergent plasmid constructs were created using Gateway technology (Kwan et al., 2007). 
The BP Clonase II enzyme catalyzes the transfer of specific DNA sequence of interest (ORF 
etc) into a donor vector using a recombination reaction releasing the ccdB/cam cassette and 
producing new recombination sites (attL1/L2). The BP clone is further recombined with two 
other plasmids containing different recombination sequences. One plasmid contains the sense 
promoter (5’prom) and another containing the inverted promoter on the 3’ end (3’ iprom) 
along with the BP clone recombine via LR clonase II Plus into a pDEST2G2 backbone 
encoding heart-specific GFP.  
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Convergent Transcription Vector Maps 
 Shown below are maps for the three Convergent Transcription (CT) vectors.  
Fully annotated sequences are available from Addgene. 
 
 
 
 
 
Figure 14. CT-mCherry Map.                                                                                                                       
The mCherry ORF was cloned directly between the zebrafish β-actin promoter and an 
inverted CMV promoter.  The β-actin and CMV promoters were obtained as 5' entry clones 
from the Tol2 kit (http://tol2kit.genetics.utah.edu/index.php/Main_Page).  The mCherry ORF 
was recombined into the above vector from a middle entry mCherry clone from the Tol2 kit.  
The non-CT-mCherry vector is identical except it lacks the inverted CMV promoter. 
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Figure 15. CT-OEP Map 
The zebrafish One Eyed Pinhead ORF was cloned directly between the zebrafish β-actin 
promoter and an inverted CMV promoter.  The OEP ORF was amplified by PCR and 
recombined into an empty middle entry vector from the Tol2 kit.  The non-CT-OEP vector is 
identical except it lacks the inverted CMV promoter. 
 
57 
 
Figure 16. CT-miR-27a/b Map 
Sequences encompassing the precursor transcripts from miR-27a and miR-27b were cloned 
directly between two zebrafish ubiquitin promoters.  Two ubi promoters from 5' and 3' entry 
vectors (see Methods) were recombined with a middle entry vector containing the precursor 
sequences for miR-27a/b.  The non-CT-miR-27a/b vector is identical except it lacks the 
reverse Ubi promoter. 
 
 
Transgenic Animals 
Transgenic animals were created using Gateway vectors and the Tol2 transgenesis 
system (http://chien.neuro.utah.edu/tol2kitwiki/index.php/Main_Page) (Kwan et al., 2007, 
Villefranc et al., 2007).  For injections, embryos from wild type AB fish were collected 
from a 15-minute mating period and microinjections of pDEST-based plasmids were 
performed (Suster et al., 2009).  Briefly, plasmid DNA and Tol2 transposase mRNAs 
were injected into 1-2 cell stage embryos.  For non-CT-mCherry and CT-mCherry, 
22.5pg plasmid DNA and 7.5pg transposase mRNAs were injected.  For CT-OEP, 
11.25pg DNA and 7.5pg transposase mRNAs was injected. For CT-miR-27a/b, 30pg 
DNA and 7.5 pg transposase mRNAs were injected. 
 
RNA isolation and sense/antisense transcript detection 
Total RNA from GFP+ 4 dpf embryos was isolated using Tri-Reagent (MRC).  20 
embryos were used per 1ml Tri-reagent.  800ng of RNA was reversed transcribed with 
M-MLV RT (Promega) using Oligo(dT)16 (Applied Bioscience) or strand-specific 
primers.  Sense and antisense transcripts were generated and quantified by SYBR green 
(BioRad) in real-time PCR (BioRad).  Transcripts were normalized to GAPDH and 
relative fold changes were normalized to values of WT embryos, set at 1, and determined 
by the ΔΔCt method (Livak et al., 2001). 
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Strand-specific primers: 
mCherry anti-sense detection: 5’ CGACATCCCCGACTACTTGAAGC 
mCherry sense detection: 5’ TCTTGGCCTTGTAGGTGGTCTT 
 
qRT-PCR primers: 
GAPDH: F- 5’ GGCAGAAGGCGGCAAACT; R- 5’ CTGGGTCCCTCTCGCTATAGA 
mCherry: F- 5’ CCCCGTAATGCAGAAGAAGA; R- 5’TCTTGGCCTTGTAGGTGGTC 
 
 
Dicer knock-down 
 Fluorescein-tagged antisense morpholinos (Gene Tools) against the 5’UTR of Dicer 
(dicerMO1) (Weinholds et al., 2003) or the translational start (dicerstart) (Thatcher et al., 
2008)  were co-injected with the CT construct and transposase mRNAs into 1-2 cell stage 
wild-type embryos of the AB strain. As a control, a mismatched Dicer MO (dicermm2) 
(Wienholds et al., 2003) was used.  Injection of either dicerMO1 and dicerstart produced the 
same phenotype and comparable levels of rescue.  Embryos were examined at 54hpf. 
 
Western blots  
At 72 hpf, GFP+ embryos were de-yolked and protein lysates were prepared from 
30 embryos in lysis buffer as described (Flynt et al., 2007).  25ug of total protein was 
loaded per lane as determined by Bradford assays (Biorad). Blots were probed with anti-
mCherry1C51 (Novus Biologicals) and anti-α-Tubulin (Abcam).  For detection, ECL 
Mouse- and ECL Rabbit-IgG-HRP-linked secondary antibodies (GE Sciences-NA931) 
were used followed by visualization with ECL (Perkin Elmer). 
 
ChIP and qPCR 
 Approximately 25-60 embryos were washed in 1X PBS.  Embryos were incubated 
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with 2.22% formaldehyde for 10 minutes at 25°C with gentle rotation.  150mM of 
glycine was used to quench the reaction for 10 minutes at 25°C with gentle rotation.  
Embryos were then washed three times with 1X PBS for 5 minutes each and then 
dissociated in ChIP Whole Cell Lysis Buffer (10mM Tris-HCl, pH 8.1, 10mM NaCl, 
3mM MgCl2, 1% NP40, 1% SDS, 0.5% DOC, and 1X protease inhibitor cocktail).  The 
protease cocktail was from Sigma (P8340).  DNA was fragmented using a probe 
sonicator (Heat Systems Ultrasonics) followed by water bath sonication (Diagenode) at 
the high setting (3 rounds of 5 minutes each).  After centrifugation for 20 minutes, 
supernatants were collected.  Reverse crosslinking of chromatin aliquots, DNA isolation, 
and fragmentation checks were performed by incubation at 65°C overnight, 
phenol/chloroform extraction, and agarose gel electrophoresis, respectively.  
Immunoprecipitation was conducted using 10ug of chromatin with 1ug of either negative 
control rabbit IgG (Cell Signaling) or H3K9me3 antibody (Diagenode pAb-056-050) 
incubated overnight at 4°C.  Magnetic Protein A beads (Millipore) were pre-washed with 
chip dilution buffer (16mM Tris-HCl, pH 8.1,162mM NaCl, .0096mg SDS, 2% Triton-X 
100) and then blocked by incubation overnight with 1.5% BSA, 0.03% protease inhibitor 
cocktail, and 0.006% of Herring sperm ssDNA at 4°C.  An equal volume of blocked bead 
solution was then added to each chromatin-antibody bound sample for 1 hour at 4°C.  
Samples were then washed for 5 minutes each with three different buffers.  Wash Buffer 
1 (20mM Tris-HCl, pH 8.1, 150mM NaCl, 2mM EDTA, 0.1% SDS, and 1% Triton X-
100), Wash Buffer 2 (20.5mM Tris-HCl, pH 8.1, 493mM NaCl, 2mM EDTA, 0.103% 
SDS, and 1% Triton X-100) and Wash Buffer 3 (10 mM Tris-HCl, pH 8.1, 1 mM EDTA, 
250mM LiCl, 1% NP-40, and 1% DOC).  Following two washes in TE buffer, antibody 
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bound chromatin was eluted in 1% SDS and 10mM NaHCO3.  Tubes were then incubated 
at 65°C overnight after addition of 200mM NaCl and then placed at 45°C after addition 
of 40mM Tris-HCl (pH 7.5), 10mM of EDTA (500mM) and 20ug of PK (20mg/mL) for 
1-2 hours.  Following reverse crosslinking, DNA was isolated (Qiagen) and dissolved in 
H20.  ChIP-qPCR was performed and quantified using Sybr green (Bio-Rad).  Fold 
enrichment was calculated by normalization of signal (H3K9me3 CT values) to 
background (IgG CT values) using the ΔΔCt method. 
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CHAPTER 3 
 
DISCUSSION 
Significance 
 The field of small RNA biology and the RNAi pathway in particular has advanced 
tremendously since the initial discovery of lin-4 and let-7. Extensive progress has been 
made towards elucidating miRNA and siRNA biogenesis including the discovery of key 
processing enzymes ---Dicer and Argonaute--- and genome wide analysis techniques 
have aided in the identification of conserved miRNAs across diverse animal species 
(Bernstein et al., 2001, Carmell et al., 2002, Bartel, D., 2004). Molecular and 
computational strategies have illuminated functionally relevant targets of many miRNAs 
and uncovered roles in development and disease (Andrews, O., & Patton, J.G., 2014, 
Singh, S.R. & Rameshwar, P., 2014). Remarkably, the gene silencing function of small 
RNAs has expanded to include regulation of chromatin at the transcriptional level, in 
addition to targeting mRNAs at the post-transcriptional level. Pioneering studies in plants 
have shown that transfection with promoter specific dsRNA produces small RNAs of ~23 
nt and induces methylation of homologous DNA sequences (Mette et al., 2000). In depth 
studies in S. pombe have also shown RNAi-mediated regulation of heterochromatin via 
H3K9me3 deposition at centromeres and regions containing CG repeats. However, the 
majority of RNAi-based gene silencing strategies in higher vertebrates rely almost 
exclusively on the PTGS mechanism. 
 In zebrafish, the use of RNAi has remained controversial in achieving sequence 
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specific gene knockdown. Silencing inefficiency is not due to the lack of functionality of 
the RNAi machinery as Dicer deficiency produces organ abnormalities and growth arrest 
at 10dpf, suggesting that Dicer and miRNA processing are crucial for zebrafish 
development (Wienholds et al., 2003). Given that the RNAi machinery is intact, the 
inconsistency in RNAi-based silencing in zebrafish is puzzling. Injection of dsRNA or 
siRNA has produced inconsistent results with some reports claiming specific silencing 
and others demonstrating high ‘off target’ effects (Wargelius et al., 1999, Li et al., 2000, 
Oates et al., 2000, Zhao et al., 2001, Mangos et al., 2001, Dodd et al., 2004, and Gruber 
et al., 2005). As a result, the majority of loss-of-function studies in zebrafish utilize 
morpholinos, which are highly specific but are short-lived with potential off-target effects 
(Bill et al., 2009). The significance of the work in this thesis is that this is the first to 
investigate and demonstrate TGS via an RNAi pathway in zebrafish. The utility of the 
convergent silencing strategy will enable spatial and temporal control by using inducible 
or tissue specific promoters. This novel strategy provides a blueprint for a simple, cheap, 
and straightforward way to silence genes in a sequence specific manner. Additionally, the 
studies outlined in this thesis may serve as a foundation to discover how widespread and 
functionally relevant endogenous convergent transcription is in zebrafish. One potential 
link to CT-like mechanism may occur with long noncoding RNAs (lncRNAs), which 
have been shown in models including mice and mammalian cells to regulate gene 
expression in cis and trans as well as interacting with chromatin modifying machinery 
(Pauli et al., 2012).  The identification of over 1100 multi-exonic noncoding transcripts in 
zebrafish embryos including intronic overlapping lncRNAs and exonic antisense 
overlapping lncRNAs that can regulate specific genes in a spatial and temporal manner is 
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promising evidence for CT-mediate silencing. In the future, this hypothesis can be tested 
by knocking down target lncRNAs and examining RNAi-mediated heterochromatin 
formation. 
                                                                                                                                    
Transcriptional Gene Silencing in zebrafish                                                                                     
 The observation that CT triggered sequence specific RNAi-mediated gene 
silencing in S. pombe and human cells prompted us to explore convergent silencing in 
zebrafish. Our data has successfully demonstrated that convergent silencing of mCherry 
expression occurs via Dicer activity and H3K9me3 deposition. Targeting of endogenous 
OEP and miR-27a/b genes successfully produced embryos that phenocopied OEP 
mutants and miR-27a/b morphants. Our work has demonstrated the utility of TGS in 
zebrafish and showed that stable silencing is achievable as observed with silencing of 
mCherry in F2 embryos via RNAi. This work also provides evidence to support the 
conservation of RNAi-mediated heterochromatin formation mechanism exemplified in S. 
pombe (Gullerova  et al., 2012).  
                                                                                                                                                    
Future Directions                                                                                      
 Convergent silencing provides an alternative tool to knockdown genes with the 
option for reversal of gene silencing.  However, there are particular limitations with our 
strategy as we observed reduced efficiency when silencing in trans compared to cis. One 
likely hindrance stems from the differing promoter strengths. We observed greater 
silencing when using distinct β–actin and CMV promoters compared to dual zebrafish 
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Ubiquitin promoters. This may suggest that using distinct promoters is more favorable for 
generating overlapping transcripts that form dsRNA and also more favorable for growth 
in competent bacteria since we observed inhibition of growth of plasmids containing dual 
β–actin promoters. The size of the promoters and the subsequent final size of the 
destination vector may also be rate limiting giving that CT-plasmids containing dual 
Ubiquitin promoters (3.5kb for each) grew compared to dual β-actin promoters (5.3kb for 
each). Another reason for reduced inefficiency could be targeting genes of high copy 
number and since the majority of our experiments were performed in AB strain, the 
finding that laboratory strains including AB contain higher number of copy number 
variants than natural “outdoor” strains supports this supposition (Brown et al., 2011).            
 One intrinsic limitation is the lack of directionality with the Tol2 transposase. A 
more improved system would precisely regulate where the convergent plasmids become 
inserted in the zebrafish genome instead of random insertion. Another limitation is the 
possible saturation of nuclear Dicer with overlapping transcripts, which may lead to 
inefficient silencing. It has been recently shown that Dicer over-expression produces 
genome wide increase of small RNAs in S. pombe (Yu et al., 2014). One approach to 
overcoming this issue is to co-inject in vitro transcribed Dicer containing a NLS (nuclear 
localization signal) with CT-constructs to increase silencing efficiency of endogenous 
genes. While this seems fairly straightforward, proper primer design and selection of 
high-fidelity polymerases is necessary to amplify Dicer due to its large size (6kb). 
However, we have to be mindful that injection of high amounts of RNA – Tol2 
transposase and NLS-tagged Dicer--- might generate some non-specific effects and 
reduce viability of embryos. Another strategy would be to either generate a stable 
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transgenic line using the Gateway vector transfer system to constitutively express tagged 
Dicer harboring an NLS signal or generate an inducible system by using a Tet-on system 
that expresses nuclear Dicer upon doxycycline addition (Campbell et al., 2012). Since we 
observed that pigment genes are refractory to CT-mediated silencing, we cannot exclude 
the possibility that other regulatory mechanisms exist to prevent TGS of specific mRNAs 
in zebrafish. Since polyadenylation signals in the 3’UTR of specific mRNAs have been 
shown to inhibit TGS in S. pombe (Yu et al., 2014), one approach would be to generate 
CT-plasmids containing 3’UTR sequences flanked by convergent promoters. If silencing 
efficiency increases, this would indicate that sequestration of the 3’UTR from interacting 
partners allows for TGS to proceed. While this experiment would not prove that signals 
within 3’UTRs prevent TGS, it may provide useful information, especially since it has 
been previously shown that shRNA vector-mediated silencing targeting the 3’UTR of 
GFP provided appreciable knockdown (Kelly, A., & Hurlstone, A.F., 2011).  
 One of the critical future aims will be to demonstrate the specificity of convergent 
silencing by examining the spread of H3K9me3 in CT-mCherry F2 embryos. ChIP-seq 
(chromatin immunoprecipitation sequencing) is the most sensitive way to select for 
H3K9me3 bound DNA, identify associated DNA sequences, and to map them back to the 
zebrafish genome to determine the localization of this heterochromatin signature. The 
expected outcome would be localized and specific H3K9me3 signature without extension 
or overlap with neighboring genes. A high throughput experiment could also be 
performed in presence and absence of Dicer using control and Dicer MO in CT-mCherry 
F2 embryos to quantitatively determine if Dicer deficiency globally reduces H3K9me3 
levels or whether specificity is restricted at convergent regions.  Another avenue to 
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explore will be to investigate the regulation of siRNA production in zebrafish 
independent of Dicer activity. In S. pombe, it has been shown that Rdp1 (RNA-dependent 
RNA polymerase) as part of a RDRC (RNA-directed RNA polymerase complex) helps to 
generate siRNAs that feedback and physically interact with the RITS complex to mediate 
RNAi-induced heterochromatin formation (Motamedi et al., 2004).  While there is no 
evidence for Rdp1 expression in vertebrates including zebrafish (Zong et al., 2009), it is 
unclear if zebrafish have devised an alternative way to amplify siRNA or if an enzyme 
(not yet discovered) is responsible for mediating this process.                                                     
 Another key aim that will provide valuable insight about TGS is to determine the 
mechanism of recognition of convergent DNA regions by siRNA-RITS complexes. 
Given the distribution and large genomes of zebrafish and the dynamic chromosomal 
landscape, it will be very interesting to discover if siRNAs bind to DNA directly or if 
other surveillance proteins remodel the chromatin to direct these siRNAs to their target. 
A potential experiment to address this would be to verify expression of RITS components 
in zebrafish and perform sequential ChIP using Ago-specific antibody for example to 
determine if RITS-associated sequences also harbor the H3K9me3 modification. 
Alternatively, convergent transcription itself might relay an epigenetic signal that then 
recruits ribonucleoprotein complexes to the convergent region.  Future work is necessary 
to answer some of these questions and to gain a better understanding of CT-mediated 
gene silencing in zebrafish. 
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